ELRIG Advances in Cell-based Screening in Drug Discovery 2026
The ELRIG Advances in Cell-based Screening in Drug Discovery 2026 event, held May 6-7 at AstraZeneca in Gothenburg, Sweden, focuses on transforming early drug discovery by shifting from animal-based to human cell-based models and integrating AI to improve predictive accuracy, with collaborative discussions aimed at redefining hit-to-lead processes for delivering transformative therapies.
ELRIG Advances in Cell-based Screening in Drug Discovery 2026
Date: May 6-7
Location: AstraZeneca, Gothenburg, Sweden
This event is essential for professionals across the cell-based discovery continuum who are actively preparing for an AI-driven future.
Through collaborative dialogue, the aim is to help the community rework early discovery from animal-gated milestones to human-first decision making. This new blueprint requires deliberation on how hit-to-lead processes should change, where cells should replace animals, and how AI can enhance the predictive accuracy of efforts to deliver transformative therapies.
Join the Dotmatics team at Booth #29 to be part of this conversation.
Event Details:
- Dates: May 6-7
- Time: 8:00 a.m. - 5:00 p.m.
- Location: AstraZeneca, Gothenburg, Sweden
Related
Dotmatics hosted Lunch & Learn
On Wednesday, September 10, 2025, at 11:30 AM EST, ABI-LAB will host a Lunch & Learn at 22 Strathmore Rd., Natick, MA, featuring Dotmatics' Principle Solutions Engineer Jessica Biagi, who will demonstrate how the Dotmatics platform integrates ELN, inventory, registration, and data analysis to enhance scientific workflows, collaboration, and accelerate discoveries.
Dotmatics Summit 2023 in Cambridge, UK
The Dotmatics Summit 2023, held October 17-18 at the Clayton Hotel in Cambridge, UK, is a day-and-a-half event featuring presentations from Dotmatics leadership and industry experts on AI-driven R&D innovation, lab integration, platform updates, and customer success stories, alongside interactive discussions and networking opportunities aimed at advancing data-driven decision making in scientific research.
Dotmatics at Lab of the Future, USA
Dotmatics is partnering with Siemens to sponsor the Lab of the Future USA Congress on March 2-3, 2026, in Boston, where Michael Swartz, Dotmatics' Chief Strategy Officer, will present on unifying science, data, and decisions to advance life science research and therapeutics development in the evolving collaborative research environment.
Biomolecular Imaging & Informatics 2022
Dotmatics is sponsoring the 9th annual Biomolecular Imaging & Informatics (SBI²) conference from September 18-20, 2022, at The Westin Copley Place in Boston, featuring topics such as spatial omics, advanced microscopy, AI and machine learning applications, high-content image-based assays, and 3D co-culture and organ-on-a-chip imaging.
Proventa | Medicinal Chemistry Strategy Meeting - Boston
The Proventa Medicinal Chemistry Strategy Meeting, held on May 25th, 2022 at Le Méridien Boston Cambridge, is a patient-centric pharmaceutical industry event featuring personalized agendas, interactive roundtable discussions, one-to-one strategic meetings, and networking opportunities designed to facilitate collaboration among industry leaders in the discovery, development, and commercialization of life-saving therapies.
The Paperless Lab Academy Europe 2023
The Paperless Lab Academy Europe 2023, an established initiative since 2012 promoting digital transformation in laboratory data management, will take place on April 18-19, 2023, starting at 8:30 am at the Grand Hotel Dino in Italy.